BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 2438039)

  • 1. Identification of an H antigen-like blood group antigen in sera of cancer patients using a novel monoclonal antibody raised against endometrial carcinoma.
    Tsuji Y; Yoshioka M; Ogasawara T; Takemura T; Isojima S
    Cancer Res; 1987 Jul; 47(13):3543-50. PubMed ID: 2438039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody (G10) to a common antigen of human squamous cell carcinoma: binding of the antibody to the H type 2 blood group determinant.
    Kimmel KA; Carey TE; Judd WJ; McClatchey KD
    J Natl Cancer Inst; 1986 Jan; 76(1):9-19. PubMed ID: 2416979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivity of monoclonal antibody DF3 with a high molecular weight antigen expressed in human ovarian carcinomas.
    Friedman EL; Hayes DF; Kufe DW
    Cancer Res; 1986 Oct; 46(10):5189-94. PubMed ID: 3530435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of a squamous cell lung carcinoma-associated antigen, KA-32, in human tissues and sera defined by monoclonal antibody KM-32.
    Hanai N; Shitara K; Yoshida H
    Cancer Res; 1986 Oct; 46(10):5206-10. PubMed ID: 3530436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological characterization of blood group A epitopes expressed on cells and tissues with a monoclonal anti-CEA antibody.
    Fiszman G; Koss A; Glait H; Horenstein A
    Haematologica; 1994; 79(2):112-8. PubMed ID: 7520408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucin-like carcinoma-associated antigen defined by three monoclonal antibodies against different epitopes.
    Stähli C; Caravatti M; Aeschbacher M; Kocyba C; Takacs B; Carmann H
    Cancer Res; 1988 Dec; 48(23):6799-802. PubMed ID: 2460229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of an anti-A human monoclonal antibody from a blood group A lung cancer patient: evidence for the occurrence of autoimmune response to difucosylated type-2 chain A.
    Inoue H; Hirohashi S; Shimosato Y; Enjoji M; Clausen H; Hakomori S
    Eur J Immunol; 1989 Dec; 19(12):2197-203. PubMed ID: 2606138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABH and related histo-blood group antigens in normal & malignant human endometrium in relation to genetic and hormonal factors.
    Skovlund VR
    APMIS Suppl; 1997; 69():1-33. PubMed ID: 9254838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas.
    Sonoda K; Nakashima M; Kaku T; Kamura T; Nakano H; Watanabe T
    Cancer; 1996 Apr; 77(8):1501-9. PubMed ID: 8608535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of lung adenocarcinoma-associated antigens in human tissues and sera defined by monoclonal antibodies KM-52 and KM-93.
    Shitara K; Hanai N; Yoshida H
    Cancer Res; 1987 Mar; 47(5):1267-72. PubMed ID: 3545444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of monoclonal antibodies against human lung squamous cell carcinoma and adenocarcinoma using mice rendered tolerant to normal human lung.
    Hanai N; Shitara K; Yoshida H
    Cancer Res; 1986 Sep; 46(9):4438-43. PubMed ID: 3731100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood group A-like activity in a long-term renal cell line.
    Leet DC; Kuhns WJ; Avis I; Avis FP
    Invest Urol; 1980 Jan; 17(4):305-9. PubMed ID: 7351362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivities of mouse monoclonal antibody K2.7 to renal cancers in complement dependent cytotoxicity and antibody dependent cell-mediated cytotoxicity.
    Kinouchi T; Bander NH; Kotake T
    J Urol; 1995 Jul; 154(1):288-92. PubMed ID: 7776448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody recognizing a determinant on type 2 chain blood group A and B oligosaccharides detects oncodevelopmental changes in azoxymethane-induced rat colon tumors and human colon cancer cell lines.
    Laferté S; Prokopishyn NL; Moyana T; Bird RP
    J Cell Biochem; 1995 Jan; 57(1):101-19. PubMed ID: 7536750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal anti-H antibody A46-B/B10 suited for differentiating blood groups A1 and A2 reveals also heterogeneity within blood group B.
    Pilgrim G; Karsten U
    Exp Clin Immunogenet; 1987; 4(2):89-94. PubMed ID: 3273416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CAR-3, a monoclonal antibody-defined antigen expressed on human carcinomas.
    Prat M; Morra I; Bussolati G; Comoglio PM
    Cancer Res; 1985 Nov; 45(11 Pt 2):5799-807. PubMed ID: 2413998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of Lewis antigen expression on erythrocytes in some cancer patients with high serum CA19-9 levels.
    Hirano K; Kawa S; Oguchi H; Kobayashi T; Yonekura H; Ogata H; Homma T
    J Natl Cancer Inst; 1987 Dec; 79(6):1261-8. PubMed ID: 2447318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of monoclonal antibodies in clinical cytology as exemplified by studies with monoclonal antibody B72.3. The George N. Papanicolaou award lecture.
    Johnston WW
    Acta Cytol; 1987; 31(5):537-56. PubMed ID: 3314301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody recognizing a carcinoembryonic antigen epitope differentially expressed in human colonic carcinoma versus normal adult colon tissues.
    Zhang HZ; Ordonez NG; Batsakis JG; Chan JC
    Cancer Res; 1989 Oct; 49(20):5766-73. PubMed ID: 2477148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A human monoclonal antibody directed to blood group i antigen: heterohybridoma between human lymphocytes from regional lymph nodes of a lung cancer patient and mouse myeloma.
    Hirohashi S; Clausen H; Nudelman E; Inoue H; Shimosato Y; Hakomori S
    J Immunol; 1986 Jun; 136(11):4163-8. PubMed ID: 2422274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.